Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Healthcare | Small Cap
Health Score : 4.53Healthcare Global Enterprises Ltd demonstrates a mixed financial performance. The company shows strong solvency due to high equity, but struggles with liquidity as indicated by low current, quick, and cash ratios. Efficiency is also a concern, with low turnover ratios suggesting challenges in asset utilization. Revenue and net income growth are absent, but the company has shown good operating profit and asset growth. Coverage ratios are weak, reflecting potential difficulties in meeting financial obligations. While profitability metrics like ROCE and ROA are strong, others such as gross profit margin and net margin are low, creating an imbalanced view. Overall, the company needs to focus on improving its liquidity and efficiency while maintaining its solvency and focusing on profitability and revenue growth.
Health Score : 4.53Healthcare Global Enterprises Ltd demonstrates a mixed financial performance. The company shows strong solvency due to high equity, but struggles with liquidity as indicated by low current, quick, and cash ratios. Efficiency is also a concern, with low turnover ratios suggesting challenges in asset utilization. Revenue and net income growth are absent, but the company has shown good operating profit and asset growth. Coverage ratios are weak, reflecting potential difficulties in meeting financial obligations. While profitability metrics like ROCE and ROA are strong, others such as gross profit margin and net margin are low, creating an imbalanced view. Overall, the company needs to focus on improving its liquidity and efficiency while maintaining its solvency and focusing on profitability and revenue growth.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
718.78
Industry Median
53.17
Small Cap Median
50.07
P/E RATIO
765.65
P/B RATIO
7.90
Industry Median
5.27
Small Cap Median
3.62
P/S RATIO
4.17
Industry Median
3.91
Small Cap Median
2.08
Others
PEG RATIO
0.00
EV/EBITDA RATIO
25.63
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹704.4 as on Sep 1, 2026.
Growth Score : 4.00The company's growth ratios show a mixed performance. While operating profit and asset growth rates are strong, revenue and net income growth are absent. The earnings per share growth is minimal suggesting challenges in translating profit into shareholder value. Overall, the company needs to focus on strategies to boost revenue and net income to achieve balanced growth.
Revenue Growth RatePoor
Operating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 38.26 | 21.22 | 12.83 | 16.25 | 14.74 |
| Operating Profit Growth Rate | 91.8 | 26.92 | 10.1 | 17.43 | 21.35 |
| Earnings Per Share (EPS) Growth | 125.03 | -45.48 | 64.32 | -7.95 | -69.44 |
| Asset Growth Rate | 9.21 | 4.19 | 16.88 | 31.06 | 10.82 |
| Net Income Growth Rate | 117.65 | -53.85 | 127.78 | 19.51 | -53.06 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Indraprastha Medical Corporation Ltd | 8.72 | 17.86 | Neutral | 267.00 | 20.03 | 184.00 |
| 2 | Jupiter Life Line Hospitals Ltd | 7.94 | 9.91 | Highly Undervalued | 343.00 | 29.19 | 194.00 |
| 3 | Artemis Medicare Services Ltd | 7.79 | 50.07 | Overvalued | 188.00 | 6.53 | 104.00 |
| 4 | Rainbow Childrens Medicare Ltd | 5.74 | 52.79 | Neutral | 544.00 | 24.62 | 282.00 |
| 5 | Yatharth Hospital & Trauma Care Services Ltd | 4.89 | 53.56 | Neutral | 292.00 | 9.90 | 170.00 |
| 6 | Healthcare Global Enterprises Ltd | 4.53 | 765.65 | Neutral | 466.00 | 0.98 | 23.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Healthcare Global Enterprises Ltd (HCG) is India's largest provider of cancer care, operating a vast network of oncology centers and multi-specialty hospitals. It offers comprehensive cancer treatment, including diagnosis, therapy, and rehabilitation. HCG also has a significant presence in fertility services, establishing itself as a leader in specialized healthcare delivery.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Healthcare Global Enterprises Ltd's P/E ratio (TTM) is 718.78, compared to the industry median of 53.17 and large cap median of 50.07.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Healthcare Global Enterprises Ltd's P/B ratio is 7.90, compared to the industry median of 5.27 and large cap median of 3.62.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Healthcare Global Enterprises Ltd's P/S ratio is 4.17, compared to the industry median of 3.91 and large cap median of 2.08.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Healthcare Global Enterprises Ltd's PEG ratio is 1.80.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Healthcare Global Enterprises Ltd's EV/EBITDA ratio is 25.63.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Healthcare Global Enterprises Ltd's ROE is 1.73%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Healthcare Global Enterprises Ltd's ROA is 11.88%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Healthcare Global Enterprises Ltd's ROCE is 8%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Healthcare Global Enterprises Ltd's operating margin is 18.31%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Healthcare Global Enterprises Ltd's net margin is 0.90%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Healthcare Global Enterprises Ltd's current ratio is 1.22.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Healthcare Global Enterprises Ltd's debt-to-equity ratio is 1.08.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Healthcare Global Enterprises Ltd's interest coverage ratio is 1.15.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Healthcare Global Enterprises Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Healthcare Global Enterprises Ltd's EPS is -69.44.
(Source line: "Ratios as of 23 Oct 2026, based on last traded price of ₹704.40. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2005
Headquarters: Bengaluru, Karnataka
Core Offerings: Comprehensive Cancer Care, Advanced Radiation Therapy, Surgical Oncology, Medical Oncology, Fertility Treatment (Milann)
Stock Listing: NSE (HCG), BSE (539787)
Promoter: Dr. B.S. Ajaikumar & Family
Healthcare Global Enterprises Ltd was incorporated in 2005. The company rapidly expanded its network, establishing itself as a pioneer in specialized cancer treatment across India. In 2012, HCG acquired a controlling stake in Milann, a leading fertility and reproductive medicine center. The company went public in 2016, listing on the NSE and BSE. HCG has continued its growth through organic expansion and strategic partnerships, focusing on advanced technology and comprehensive patient care.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Oncology | Approx. 85-90% | Operating Profit |
| Fertility (Milann) | Approx. 10-15% | Operating Profit |
Oncology: HCG operates a comprehensive network of cancer care centers offering diagnostic services, medical oncology, surgical oncology, radiation oncology, and palliative care. It deploys advanced technologies like CyberKnife and TrueBeam.
Fertility (Milann): Through its subsidiary Milann, HCG provides a full spectrum of fertility services, including IVF, IUI, egg freezing, and reproductive endocrinology, catering to a growing demand for fertility treatments.
Dr. B.S. Ajaikumar - Executive Chairman and CEO. He is the founder of HCG and a highly respected medical oncologist with extensive experience in cancer care delivery and hospital management.
Milann Fertility & Research Centre Pvt. Ltd. (operates fertility clinics)
HCG Oncology Services Pvt. Ltd. (manages various oncology centers)
No major recent corporate actions on record.
The Healthcare Global Enterprises Ltd share price today is ₹704.40 on NSE (HCG), as of 23 Oct 2026.
As of 23 Oct 2026, Healthcare Global Enterprises Ltd share price is ₹704.40, with previous close ₹704.40. Today's range is ₹704.40 to ₹704.40. The 52-week range is ₹513.30 to ₹775.
As of today, Healthcare Global Enterprises Ltd's market cap is ₹10,601.22 crore (Mid Cap).
Healthcare Global Enterprises Ltd's current P/E ratio is 718.78, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 55.
Healthcare Global Enterprises Ltd's current P/B ratio is 7.90.
Healthcare Global Enterprises Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Healthcare Global Enterprises Ltd's EPS (TTM) is ₹-69.44.
Healthcare Global Enterprises Ltd (HCG) is India's largest provider of cancer care, operating a vast network of oncology centers and multi-specialty hospitals. It offers comprehensive cancer treatment, including diagnosis, therapy, and rehabilitation. HCG also has a significant presence in fertility services, establishing itself as a leader in specialized healthcare delivery.
Healthcare Global Enterprises Ltd is promoted by Dr. B.S. Ajaikumar & Family, holding 64.21% as of 23 Oct 2026.
Healthcare Global Enterprises Ltd is listed on NSE (HCG) and BSE (539787). Its next quarterly results are expected on August 2024 (for Q1 FY25).
Shareholding & Ownership Structure
